Core-binding factor: A central player in hematopoiesis and leukemia

Cancer Research

Volumn 59, Issue 7 SUPPL., 1999, Pages

  Speck, Nancy A ^a   Stacy, Terry ^a   Wang, Qing ^a   North, Trista ^a   Gu, Ting Lei ^a   Miller, Janelle ^a   Binder, Michael ^a   Marín Padilla, Miguel ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HYBRID PROTEIN; TRANSCRIPTION FACTOR;

CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; DNA BINDING; GENE DISRUPTION; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ANIMALS; CORE BINDING FACTORS; DNA-BINDING PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; LEUKEMIA, EXPERIMENTAL; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0033118155     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Speck, N. A., and Stacy, T. A new transcription factor family associated with human leukemias. In: G. S. Stein, J. L. Stein, and J. B. Lian (eds.), Critical Reviews in Eukaryotic Gene Expression, pp. 337-364. New York: Begell House, Inc., 1995.
2. Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., and Shigesada, K. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology, 194: 314-331, 1993.
3. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., and Ito, Y. PEBP2/PEA2 represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1 gene. Proc. Natl. Acad. Sci. USA, 90: 6859-6863, 1993.
4. Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., and Speck, N. A. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol., 13: 3324-3339, 1993.
5. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA, 88: 10431-10434, 1991.
6. Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L., and Groner, Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics, 23: 425-432, 1994.
7. Bae, S-C., Takahashi, E., Zhang, Y. W., Ogawa, E., Shigesada, K., Namba, Y., Satake, M., and Ito, Y. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene (Amst.), 159: 245-248, 1995.
8. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W. H., Beddington, R. S. P., Mundlos, S., Olsen, B. R., Selby, P. B., and Owen, M. J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 89: 765-772, 1997.
9. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y-H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89: 755-764, 1997.
10. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H. M., Owen, M. J., Mertelsmann, R., Zabel, B. U., and Olsen, B. R. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 89: 773-780, 1997.
11. Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., and Gilliland, D. G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA, 92: 4917-4921, 1995.
12. Romana, S. P., Mauchauffe, M., Le Coniat, M., Chumakow, I., Le Paslier, D., Berger, R. and Bernard, O. A. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood, 85: 3662-3670, 1995.
13. Nucifora, G., Begy, C. R., Erickson, P., Drabkin, H. A., and Rowley, J. D. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA, 90: 7784-7788, 1993.
14. Nucifora, G., Begy, C. R., Kobayashi, H., Roulston, D., Claxton, D., Pedersen-Bjergaard, J., Parganas, E., Ihle, J. N., and Rowley, J. D. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl. Acad. Sci. USA, 91: 4004-4008, 1994.
15. Liu, P., Tarle, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., and Collins, F. S. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science (Washington, DC), 261: 1041-1044, 1993.
16. Bitter, M. A., LeBeau, M. M., Rowley, J. D., Larson, R. A., Golomb, H. M., and Vardiman, J. W. Association between morphology, karyotype, and clinical features in myeloid leukemias. Hum. Pathol., 18: 211-225, 1987.
17. McLean, T. W., Ringold, S., Neuberg, D., Stegmaier, K., Tantravahi, R., Ritz, J., Koeffler, H. P., Takeuchi, S., Janssen, J. W., Seriu, T., Bartram, C. R., Sallan, S. E., Gilliland, D. G., and Golub, T. R. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood, 88: 4252-4258, 1996.
18. Romana, S. P., Poirel, H., Leconiat, M., Flexor, M-A., Mauchauffe, M., Jonveaux, P., Macintyre, E. A., Berger, R., and Bernard, O. A. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86: 4263-4269, 1995.
19. Shurtleff, S. A., Buijs, A., Behm, F. G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G. C-F., Pui, C-H., Grosveld, G., and Downing, J. R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia (Baltimore), 9: 1985-1989, 1995.
20. Shurtleff, S. A., Meyers, S., Hiebert, S. W., Raimondi, S. C., Head, D. R., Willman, C. L., Wolman, S., Slovak, M. L., Carroll, A. J., Behm, F., Hulshof, M. G., Motroni, T. A., Okuda, T., Liu, P., Collins, F. S., and Downing, J. R. Heterogeneity in CBFB/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16; 16)(p13;q22) in acute myelogenous leukemia. Blood, 85: 3695-3703, 1995.
21. Meyers, S., Lenny, N., and Hiebert, S. W. The t(8;21) fusion protein interferes with AML1-1B-dependent transcriptional activation. Mol. Cell. Biol., 15: 1974-1982, 1995.
22. Lenny, N., Meyers, S., and Hiebert, S. W. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene, 11: 1761-1769, 1995.
23. Hiebert, S. W., Sun, W., Davis, N., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gilliland, D. G., Lenny, N., and Meyers, S. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol., 16: 1349-1355, 1996.
24. Tanaka, T., Mitani, K., Kurokawa, M., Ogawa, S., Tanaka, K., Nishida, J., Yazaki, Y., Shibata, Y., and Hirai, H. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol. Cell. Biol., 15: 2383-2392, 1995.
25. Zent, C. S., Mathieu, C., Claxton, D. F., Zhang, D. E., Tenen, D. G., Rowley, J. D., and Nucifora, G. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSFIR promoter, but only AML1/MDS1 has tumor-promoter properties. Proc. Natl. Acad. Sci. USA, 93: 1044-1048, 1996.
26. Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Speck, N. A., and Zhang, D-E. Embryonic lethality and impairment of hematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet., 15: 303-306, 1997.
27. Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C., van Deursen, J. M. A., Harada, H., and Downing, J. R. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood, 91: 3134-3143, 1998.
28. Liu, P., Seidel, N., Bodine, D., Speck, N., Tarle, S., and Collins, F. S. Acute myelomonocytic leukemia with inv(16) produces a chimeric transcription factor with a myosin heavy chain tail. Cold Spring Harbor Symp. Quan. Biol. Mol. Genet. Cancer, 59: 547-553, 1994.
29. Liu, P. P., Hajra, A., Wijmenga, C., and Collins, F. S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood, 85: 2289-2302, 1995.
30. Wijmenga, C., Gregory, P. E., Hajra, A., Schröck, E., Ried, T., Iels, R., Liu, P. P., and Collins, F. S. Core binding factor β-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells. Proc. Natl. Acad. Sci. USA, 93: 1630-1635, 1996.
31. Moore, M. A. S., and Metcalf, D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br. J. Haematol., 18: 279-296, 1970.
32. Yoder, M. C., Hiatt, K., Dutt, P., Mukherjee, P., Bodine, D. M., and Orlic, D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity, 7: 335-344, 1997.
33. Garcia-Porrero, J. A., Godin, I. E., and Dieterlen-Lièvre, F. Potential intraembryonic hemogenic sites at pre-liver stages in the mouse. Anat. Embryol., 192: 425-435, 1995.
34. Godin, I., Dieterlen-Lièvre, F., and Cumano, A. Emergence of multipotent hematopoietic cells in the yolk sac and paraaortic splanchnopleura of 8.5 dpc mouse embryos. Proc. Natl. Acad. Sci. USA, 92: 773-777, 1995.
35. Cumano, A., Dieterlen-Lièvre, F., and Godin, I. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell, 86: 907-916, 1996.
36. Müller, A. M., Medvinsky, A., Strouboulis, J., Grosveld, F., and Dzierzak, E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity, 1: 291-301, 1994.
37. Medvinsky, A., and Dzierzak, E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell, 86: 897-906, 1996.
38. Orkin, S. H. Transcription factors and hematopoietic development. J. Biol. Chem., 270: 4955-4958, 1995.
39. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., and Downing, J. R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84: 321-330, 1996.
40. Wang, Q., Stacy, T., Binder, M., Marín-Padilla, M., Sharpe, A. H., and Speck, N. A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA, 93: 3444-3449, 1996.
41. Wang, Q., Stacy, T., Miller, J. D., Lewis, A. F., Huang, X., Bones, J-C., Bushweller, J. H., Alt, F. W., Binder, M., Marín-Padilla, M., Sharpe, A., and Speck, N. A. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell, 87: 697-708, 1996.
42. Sasaki, K., Vagi, H., Bronson, R. T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T., and Komori, T. Absence of fetal liver hematopoiesis in transcriptional co-activator, core binding factor β (Cbfb) deficient mice. Proc. Natl. Acad. Sci. USA, 93: 12359-12363, 1996.
43. Niki, M., Okada, H., Takano, H., Kuno, J., Tani, K., Hibino, H., Asano, S., Ito, Y., Satake, M., and Noda, T. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA, 94: 5697-5702, 1997.
44. North, T., Gu, T-L., Stacy, T., Wang, Q., Howard, L., Binder, M., Marín-Padilla, M., and Speck, N. A. Cbfa2 is required for the formation of intraaortic hematopoietic clusters. Development (Camb.), in press, 1999.
45. Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., and Hiebert, S. W. The t(8;21) fusion product, AML-1-ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol., 18: 322-333, 1998.
46. Cao, W., Britos-Bray, M., Claxton, D. F., Kelley, C. A., Speck, N. A., Liu, P. P., and Friedman, A. D. CBFβ-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells. Oncogene, 15: 1315-1327, 1997.
47. Castilla, L. H., Wijmenga, C., Wang, Q., Stacy, T., Speck, N. A., Eckhaus, M., Marín-Padilla, M., Collins, F. S., Wynshaw-Boris, A., and Liu, P. P. Defects of embryonic hematopoiesis and lethal hemorrhaging in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell, 87: 687-696, 1996.